Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Tychon Biosciences logo — Advancing new therapies that direct the body how to fight an...

Tychon Biosciences

Advancing new therapies that direct the body how to fight and beat cancer.

Founded 2015 1 employees Angel Biopharma, Biotechnology +1

General Information

Company Name Tychon Biosciences
Founded Year 2015
Employees 1
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Angel
Social

BounceWatch is an independent company data service, not affiliated with Tychon Biosciences. To contact Tychon Biosciences, visit tychonbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Tychon Biosciences compare?

A PDF of Tychon Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Tychon Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Tychon Biosciences

Tychon Biosciences is a biotechnology company founded in 2015, specializing in the Immuno-oncology marketplace. The company's slogan "Advancing new therapies that direct the body how to fight and beat cancer" encapsulates their mission to provide innovative solutions in cancer treatment. Tychon Biosciences is focused on commercializing a first-in-class bi-specific nanoring platform called BiND, which targets both an antigen receptor on a cancer cell and T-cell, enabling natural T-cell attacks on cancer cells without genetic engineering. This technology offers high-specificity cancer killing with increased safety and decreased cost compared to existing therapies. The company operates in the Biopharma, Biotechnology, and Life Sciences industries, reflecting its commitment to cutting-edge medical advancements. Currently, specific details regarding headquarters and last investment are not available. Tychon Biosciences presents an intriguing opportunity for investors seeking to support groundbreaking technologies in the fight against cancer.

No funding data available for Tychon Biosciences yet.

Tychon Biosciences Alternatives & Competitors

Tychon Biosciences vs
Prescient Therapeutics
Prescient Therapeutics Australia

A clinical stage oncology company developing personalised medicine approaches to cancer; cellular &...

Post-IPO Equity
14 employees
Biopharma, Biotechnology
Tychon Biosciences vs
Sensei Bio
Sensei Bio United States

We follow the immune system’s teachings to discover new treatments that inspire the body to fight ca...

Series B
32 employees
Biotechnology, Health Care

FAQ About Tychon Biosciences

Advancing new therapies that direct the body how to fight and beat cancer.
Tychon Biosciences was founded in 2015.
Tychon Biosciences operates in Biopharma, Biotechnology and Life Sciences.
Tychon Biosciences has approximately 1 employees.
Top alternatives and competitors to Tychon Biosciences include Prescient Therapeutics, Sensei Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tychon Biosciences and Prescient Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Tychon Biosciences, https://bouncewatch.com/company/tychon-biosciences, updated 24 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout